JP2020002127A - Esculin lipoic acid ester with antioxidant activity and method of preparing the same - Google Patents
Esculin lipoic acid ester with antioxidant activity and method of preparing the same Download PDFInfo
- Publication number
- JP2020002127A JP2020002127A JP2019115839A JP2019115839A JP2020002127A JP 2020002127 A JP2020002127 A JP 2020002127A JP 2019115839 A JP2019115839 A JP 2019115839A JP 2019115839 A JP2019115839 A JP 2019115839A JP 2020002127 A JP2020002127 A JP 2020002127A
- Authority
- JP
- Japan
- Prior art keywords
- esculin
- compound
- reaction mixture
- lipoic acid
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 8
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 title abstract description 30
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 title abstract description 30
- 229940093496 esculin Drugs 0.000 title abstract description 30
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 title abstract description 30
- 235000019136 lipoic acid Nutrition 0.000 title abstract description 17
- 229960002663 thioctic acid Drugs 0.000 title abstract description 17
- 230000003078 antioxidant effect Effects 0.000 title abstract description 7
- -1 Esculin lipoic acid ester Chemical class 0.000 title abstract description 6
- 239000011541 reaction mixture Substances 0.000 claims description 29
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 24
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 15
- HTZCNXWZYVXIMZ-UHFFFAOYSA-M benzyl(triethyl)azanium;chloride Chemical group [Cl-].CC[N+](CC)(CC)CC1=CC=CC=C1 HTZCNXWZYVXIMZ-UHFFFAOYSA-M 0.000 claims description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 10
- 238000000527 sonication Methods 0.000 claims description 6
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 6
- 239000003054 catalyst Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 9
- 235000006708 antioxidants Nutrition 0.000 abstract description 8
- 235000013305 food Nutrition 0.000 abstract description 4
- 239000002778 food additive Substances 0.000 abstract description 4
- 239000000490 cosmetic additive Substances 0.000 abstract description 2
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 26
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 230000000598 lipoate effect Effects 0.000 description 14
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical class [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- 239000012488 sample solution Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000008589 Cortex Fraxini Substances 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 230000002292 Radical scavenging effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000006701 autoxidation reaction Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000019261 food antioxidant Nutrition 0.000 description 1
- 239000003574 free electron Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002831 nitrogen free-radicals Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000008829 qinpi Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Description
本発明は、2018年6月22日に出願された中国特許出願第CN201810649366.X号に対する優先権を主張し、その内容は、本明細書に完全に記載されているかのようにあらゆる目的のために参照することにより援用される。 The present invention relates to Chinese Patent Application No. CN201810649366. Filed on June 22, 2018. Claims priority to Issue X, the contents of which are incorporated by reference for all purposes as if fully set forth herein.
本発明は食品および化粧品添加剤、特に酸化防止活性を有するエスクリンリポ酸エステルおよびその製造方法に関する。 The present invention relates to food and cosmetic additives, particularly to esculin lipoate having antioxidant activity and a method for producing the same.
食品添加物産業の技術的進歩のために、食品酸化防止剤の開発、製造、および適用が非常に進歩している。酸化防止剤は重要な食品添加物である。これは主に食品中の油の自動酸化を防止または遅延させるために使用される。それはまた貯蔵中の酸化による、栄養素の損傷、褐変、および退色を防止する。同時に、近年、研究によって、酸化および紫外線照射によって人間の肌が老化することが明らかになっているので、化粧品業界ではますます多くの酸化防止剤も使用されている。新しい酸化防止剤を開発するために、さらに研究が進められている。合成酸化防止剤および半合成酸化防止剤がますます注目を集めている。 Due to technological advances in the food additive industry, the development, manufacture, and application of food antioxidants have greatly advanced. Antioxidants are important food additives. It is mainly used to prevent or delay the autoxidation of oils in foods. It also prevents nutrient damage, browning, and fading due to oxidation during storage. At the same time, more and more antioxidants are also used in the cosmetics industry, as research has shown in recent years that human skin ages due to oxidation and UV irradiation. Further research is underway to develop new antioxidants. Synthetic and semi-synthetic antioxidants are receiving increasing attention.
エスクリン(式IIの化合物)は、モクセイ属のオレインツリーの乾燥樹皮または乾燥表皮から抽出されたクマリン化合物であり、漢方薬Qinpi(Cortex Fraxini)の有効成分である。エスクリンには、抗炎症作用、抗菌作用、利尿作用、および抗腫瘍作用がある。酸化防止剤としてのエスクリンの使用に関する報告は無い。
リポ酸(α−リポ酸およびアルファリポ酸としても知られている、式IIIの化合物)はミトコンドリア中に存在する補酵素であり、ビタミンと同様に、老化および病気を加速するフリーラジカルを排除する。リポ酸は、体内で腸に吸収された後に細胞に入る。それは脂溶性および水溶性の両方の性質を有する。それは心臓病や糖尿病などの様々な病気の治療と予防に使用されている。それはビタミンCおよびEのような他の酸化防止剤を保存し、再生すると考えられている。
一実施形態では、本発明は、以下の式Iの化合物(エスクリンリポ酸エステル)を提供する。
一実施形態では、本発明は、式Iの化合物を調製する方法を提供する。当該方法は、式IIの化合物を式IIIの化合物と反応させて式Iの化合物を得ることを含む。
別の実施形態において、式IIの化合物と式IIIの化合物との反応は、式IIの化合物と式IIIの化合物とを1:1〜1:1.3のモル比で反応器内に配する工程、有機溶媒、N,N´−ジシクロヘキシルカルボジイミド(DCC)、および触媒を添加して反応混合物を得る工程、ならびに、超音波処理下で当該反応混合物を30〜55℃で3〜4時間加熱する工程、を含む。 In another embodiment, the reaction of the compound of Formula II with the compound of Formula III places the compound of Formula II and the compound of Formula III in a molar ratio of 1: 1 to 1: 1.3 in the reactor. Adding an organic solvent, N, N'-dicyclohexylcarbodiimide (DCC), and a catalyst to obtain a reaction mixture, and heating the reaction mixture under sonication at 30-55 ° C. for 3-4 hours. Process.
他の実施形態において、有機溶媒はアセトニトリルまたはTHFであり、かつ、触媒は塩化ベンジルトリエチルアンモニウムまたは塩化チオニルである。 In another embodiment, the organic solvent is acetonitrile or THF, and the catalyst is benzyltriethylammonium chloride or thionyl chloride.
前述の一般的な説明および以下の詳細な説明は両方とも例示的かつ説明的なものであり、特許請求の範囲に記載された本発明をさらに説明するためのものであることを理解されたい。 It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed.
本発明のさらなる理解を提供するために含まれ、本明細書に組み込まれてその一部を構成する添付の図面は、本発明の実施形態を例示し、その説明とともに本発明の原理を説明するのに役立つ。 The accompanying drawings, which are included to provide a further understanding of the invention, and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and, together with the description, explain the principles of the invention. Help.
ここで本発明の実施形態を詳細に参照するが、その例は添付の図面に示されている。以下の実施例は本発明を説明するが、本発明は以下の実施例に限定されない。 Reference will now be made in detail to embodiments of the invention, examples of which are illustrated in the accompanying drawings. The following examples illustrate the invention, but the invention is not limited to the examples.
〔実施例1〕
エスクリンリポ酸エステル(式Iの化合物)の調製
[Example 1]
Preparation of esculin lipoate (compound of formula I)
エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化チオニル3.5mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で35℃で4時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去して、エスクリンリポ酸エステル137.9mgを得た(収率88.79%)。 100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 3.5 mg of thionyl chloride were added to the reaction mixture. The reaction mixture was heated at 35 ° C. under sonication and nitrogen atmosphere for 4 hours. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Then, the solvent in the reaction mixture was removed to obtain 137.9 mg of esculin lipoate (88.79% yield).
1H NMR (400 MHz, DMSO-d6) δ (ppm): 7.74 (1H, d), 6.87(1H, s), 6.73 (1H, s), 5.90 (1H, d), 5.81 (1H, d), 5.31 (1H, s), 4.01-4.30 (3H, m), 3.89 (1H, t), 3.52 (3H, s), 3.39-3.50 (2H, m), 2.63-2.49 (3H, m), 2.30 (2H, t), 2.00-1.71 (4H, m), 1.53 (2H, q), 1.28 (2H, m); 13C NMR (400 MHz, DMSO-d6) δ (ppm): 173.4, 160.6, 148.6, 145.8, 143.0, 113.6, 111.0, 109.7, 102.7, 78.9, 76.3, 73.6, 71.5, 63.4, 40.7, 38.3, 34.0, 29.3, 28.1; MS (ESI) for (M+H)+: 529.12 1 H NMR (400 MHz, DMSO-d6) δ (ppm): 7.74 (1H, d), 6.87 (1H, s), 6.73 (1H, s), 5.90 (1H, d), 5.81 (1H, d) , 5.31 (1H, s), 4.01-4.30 (3H, m), 3.89 (1H, t), 3.52 (3H, s), 3.39-3.50 (2H, m), 2.63-2.49 (3H, m), 2.30 (2H, t), 2.00-1.71 (4H, m), 1.53 (2H, q), 1.28 (2H, m); 13 C NMR (400 MHz, DMSO-d 6 ) δ (ppm): 173.4, 160.6, 148.6, 145.8, 143.0, 113.6, 111.0, 109.7, 102.7, 78.9, 76.3, 73.6, 71.5, 63.4, 40.7, 38.3, 34.0, 29.3, 28.1; MS (ESI) for (M + H) + : 529.12
〔実施例2〕
エスクリンリポ酸エステルの調製
[Example 2]
Preparation of esculin lipoate
エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化ベンジルトリエチルアンモニウム(TEBAC)6.7mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で45℃で4時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去して、エスクリンリポ酸エステル121.3mgを得た(収率78.14%)。 100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 6.7 mg of benzyltriethylammonium chloride (TEBAC) were added to the reaction mixture. The reaction mixture was heated at 45 ° C. under sonication and a nitrogen atmosphere for 4 hours. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Next, the solvent in the reaction mixture was removed to obtain 121.3 mg of esculin lipoic acid ester (78.14% yield).
〔実施例3〕
エスクリンリポ酸エステルの調製
[Example 3]
Preparation of esculin lipoate
エスクリン100mg(0.29mmol)およびリポ酸78.7mg(0.38mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化チオニル3.5mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で55℃で3時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去して、エスクリンリポ酸エステル129.3mgを得た(収率83.26%)。 100 mg (0.29 mmol) of esculin and 78.7 mg (0.38 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 3.5 mg of thionyl chloride were added to the reaction mixture. The reaction mixture was sonicated and heated at 55 ° C. under a nitrogen atmosphere for 3 hours. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Next, the solvent in the reaction mixture was removed to obtain 129.3 mg of esculin lipoic acid ester (83.26% yield).
〔実施例4〕
エスクリンリポ酸エステルの調製
[Example 4]
Preparation of esculin lipoate
エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化チオニル3.5mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で30℃で3時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。次いで反応混合物中の溶媒を除去してエスクリンリポ酸エステル124.4mgを得た(収率80.11%)。 100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 3.5 mg of thionyl chloride were added to the reaction mixture. The reaction mixture was heated at 30 ° C. for 3 hours under sonication and nitrogen atmosphere. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Then, the solvent in the reaction mixture was removed to obtain 124.4 mg of esculin lipoate (yield: 80.11%).
〔実施例5〕
エスクリンリポ酸エステルの調製
[Example 5]
Preparation of esculin lipoate
エスクリン100mg(0.29mmol)およびリポ酸66.6mg(0.32mmol)を100mL反応器に入れた。アセトニトリル60mLを添加して反応混合物を形成した。次いで、DCC61.9mg(0.3mmol)および塩化ベンジルトリエチルアンモニウム(TEBAC)6.7mgを反応混合物に添加した。反応混合物を超音波処理および窒素雰囲気下で、50℃で4時間加熱した。反応混合物を室温に冷却し、減圧下で濃縮し、濾過し、硫酸ナトリウムで乾燥した。その後、反応混合物中の溶媒を除去して、エスクリンリポ酸エステル130.9mgを得た(収率84.28%)。 100 mg (0.29 mmol) of esculin and 66.6 mg (0.32 mmol) of lipoic acid were placed in a 100 mL reactor. 60 mL of acetonitrile was added to form a reaction mixture. Then 61.9 mg (0.3 mmol) of DCC and 6.7 mg of benzyltriethylammonium chloride (TEBAC) were added to the reaction mixture. The reaction mixture was heated at 50 ° C. for 4 hours under sonication and nitrogen atmosphere. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, filtered, and dried over sodium sulfate. Thereafter, the solvent in the reaction mixture was removed to obtain 130.9 mg of esculin lipoate (84.28% yield).
〔実施例6〕
DPPHラジカルスカベンジング活性アッセイにより測定されるエスクリンリポ酸エステルの酸化防止活性
[Example 6]
Antioxidant activity of esculin lipoate as measured by DPPH radical scavenging activity assay
2,2−ジフェニル−1−ピクリルヒドラジル(DPPH)は安定な有機ラジカルからなる有機化合物である。DPPH分子においては、複数の電子求引性NO2およびベンゼン環の大きなπ結合の存在により、窒素フリーラジカルが安定化されている。そのメタノール溶液は紫色であり、517nmに最大吸収ピークを有する。酸化防止剤の添加後、DPPHは自由電子と対になる電子を捕獲し、紫色は退色して黄色の物質に変わる。517nmでの吸収は消え、退色の程度はそれが捕獲する電子の数と定量的に関係している。この原理に基づいて、分光光度計を使用してDPPHラジカルとサンプル溶液の吸光度の変化を検出し、サンプルが水素原子を供給してフリーラジカルを除去する能力を測定することができる。 2,2-Diphenyl-1-picrylhydrazyl (DPPH) is an organic compound composed of stable organic radicals. In the DPPH molecule, nitrogen free radicals are stabilized by the presence of a plurality of electron-withdrawing NO 2 and a large π bond of a benzene ring. The methanol solution is purple and has a maximum absorption peak at 517 nm. After addition of the antioxidant, DPPH captures electrons that are paired with free electrons, and the purple color fades to a yellow substance. The absorption at 517 nm disappears and the degree of fading is quantitatively related to the number of electrons it captures. Based on this principle, a spectrophotometer can be used to detect changes in DPPH radicals and the absorbance of the sample solution and determine the ability of the sample to supply hydrogen atoms and remove free radicals.
《DPPH溶液の調製》
正確な量の2,2−ジフェニル−1−ピクリルヒドラジル(DPPH)を測定し、メタノールに溶解して、0.2mmol/LのDPPH溶液を調製し、0℃で暗所に保存する。
<< Preparation of DPPH solution >>
An accurate amount of 2,2-diphenyl-1-picrylhydrazyl (DPPH) is measured, dissolved in methanol to prepare a 0.2 mmol / L DPPH solution, and stored at 0 ° C. in a dark place.
《サンプル溶液の調製》
エスクリンリポ酸エステルをアセトニトリルで1.82、7.28、24.2、48.4、72.6、96.8、242、484、726および968ppmの濃度勾配で希釈して、試験すべきサンプル溶液を調製した。対照サンプル(ビタミンC、エスクリン、リポ酸、エスクリンとリポ酸との混合物)をメタノールで同じ濃度勾配で同様に希釈して、対応する4群の対照溶液を得た。
<< Preparation of sample solution >>
The sample solution to be tested is prepared by diluting the esculin lipoate with acetonitrile in a gradient of 1.82, 7.28, 24.2, 48.4, 72.6, 96.8, 242, 484, 726 and 968 ppm. Was prepared. Control samples (vitamin C, esculin, lipoic acid, a mixture of esculin and lipoic acid) were similarly diluted with methanol at the same concentration gradient to obtain four corresponding groups of control solutions.
《具体的な工程:サンプル溶液のスカベンジング活性の測定》
各濃度勾配でサンプル溶液2mLを取り、0.2mmol/LのDPPH溶液2mLを添加し、混合物を混合し、室温で30分間暗所で反応させ、次いでメタノールを添加して最終容量を調整した。吸光度Aiを517nmで測定した。対照溶液2mLとメタノール2mLとを混合し、吸光度Ajを測定した。DPPH溶液2mLとメタノール2mLとを混合し、吸光度A0を測定した。サンプル溶液および対照溶液のスカベンジング活性は、以下の計算式に従って算出される。
スカベンジング活性(%)=100×[1−(Ai−Aj)/A0]
<< Specific process: Measurement of scavenging activity of sample solution >>
2 mL of the sample solution was taken at each concentration gradient, 2 mL of a 0.2 mmol / L DPPH solution was added, the mixture was mixed, allowed to react at room temperature for 30 minutes in the dark, and then methanol was added to adjust the final volume. The absorbance A i was measured at 517nm. 2 mL of the control solution and 2 mL of methanol were mixed, and the absorbance Aj was measured. Mixing the DPPH solution 2mL methanol 2mL, and the absorbance was measured A 0. The scavenging activity of the sample solution and the control solution is calculated according to the following formula.
Scavenging activity (%) = 100 × [1- (A i -A j ) / A 0 ]
スカベンジング活性を表1および図1に示す。図1において、X軸はサンプルおよび対照溶液の濃度(PPM)を表し、Y軸はスカベンジング活性を表す。 The scavenging activity is shown in Table 1 and FIG. In FIG. 1, the X-axis represents the concentration of the sample and the control solution (PPM), and the Y-axis represents the scavenging activity.
表1:スカベンジング活性
試験結果は、エスクリンリポ酸エステルの酸化防止活性がビタミンCのそれと類似しており、90%を超えるフリーラジカルクリアランス率をより低い濃度で達成することができ、これは、エスクリン、リポ酸、およびエスクリンとリポ酸との混合物、より著しく高いことを示している。エスクリンリポ酸エステルは、食品および化粧品用酸化防止添加剤として使用することができ、幅広い用途の見込みがある。 The test results show that the antioxidant activity of esculin lipoate is similar to that of vitamin C, and that free radical clearance rates of more than 90% can be achieved at lower concentrations, due to esculin, lipoic acid, and esculin And a mixture of lipoic acid, showing significantly higher. Esculin lipoate can be used as an antioxidant additive for food and cosmetics and has widespread application prospects.
本発明の精神または範囲を逸脱することなく本発明に様々な修正および変更を加えることができることは当業者には明らかであろう。したがって、本発明は、添付の特許請求の範囲およびそれらの均等物の範囲内にある限り、本発明の修正形態および変形形態を網羅することを意図している。 It will be apparent to those skilled in the art that various modifications and variations can be made to the present invention without departing from the spirit or scope of the invention. Thus, it is intended that the present invention cover the modifications and variations of this invention provided they come within the scope of the appended claims and their equivalents.
Claims (4)
前記式IIの化合物および前記式IIIの化合物を1:1〜1:1.3のモル比で反応器内に配する工程、
有機溶媒、N,N´−ジシクロヘキシルカルボジイミド、および触媒を添加して反応混合物を得る工程、ならびに、
超音波処理下で前記反応混合物を30〜55℃で3〜4時間加熱する工程、を含む請求項2に記載の方法。 Wherein the reaction of the compound of Formula II with the compound of Formula III comprises:
Disposing the compound of the formula II and the compound of the formula III in a reactor in a molar ratio of 1: 1 to 1: 1.3,
Adding an organic solvent, N, N′-dicyclohexylcarbodiimide, and a catalyst to obtain a reaction mixture; and
Heating the reaction mixture under sonication at 30-55 ° C for 3-4 hours.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810649366.X | 2018-06-22 | ||
CN201810649366.XA CN108794459A (en) | 2018-06-22 | 2018-06-22 | A kind of aesculin lipoate compound and preparation method thereof with antioxidant activity |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020002127A true JP2020002127A (en) | 2020-01-09 |
JP6741315B2 JP6741315B2 (en) | 2020-08-19 |
Family
ID=64084269
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019115839A Expired - Fee Related JP6741315B2 (en) | 2018-06-22 | 2019-06-21 | Esculin lipoic acid ester having antioxidant activity and method for producing the same |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP6741315B2 (en) |
CN (1) | CN108794459A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109620840A (en) * | 2018-12-27 | 2019-04-16 | 江苏隆力奇生物科技股份有限公司 | A kind of pharmaceutical composition and its application of anti-skin photoage |
CN113214194A (en) * | 2021-04-14 | 2021-08-06 | 张洪胜 | Andrographolide gallate compound with antioxidant activity and preparation method thereof |
-
2018
- 2018-06-22 CN CN201810649366.XA patent/CN108794459A/en active Pending
-
2019
- 2019-06-21 JP JP2019115839A patent/JP6741315B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN108794459A (en) | 2018-11-13 |
JP6741315B2 (en) | 2020-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6741315B2 (en) | Esculin lipoic acid ester having antioxidant activity and method for producing the same | |
Rodriguez-Naranjo et al. | Comparative evaluation of the antioxidant activity of melatonin and related indoles | |
US9174983B2 (en) | Pyrroloquinoline quinone disodium salt crystal and method for producing the same | |
AU2014278362B2 (en) | Preparation of (S,S)-secoisolariciresinol diglucoside and (R,R)-secoisolariciresinol diglucoside | |
Li et al. | Synthesis, characterization, solubilization, cytotoxicity and antioxidant activity of aminomethylated dihydroquercetin | |
CN111643452A (en) | Oxyresveratrol nanoemulsion as well as preparation method and application thereof | |
JP6940197B2 (en) | Hydroxytyrosol dihydrocafe art with antioxidant activity and its preparation method | |
CN107674056A (en) | Its application in hyperuricemia is treated of Versulin derivative | |
JP6893051B6 (en) | Hydroxytyrosol isophorone diisocyanate derivative with antioxidant activity and its preparation method | |
CN112812121B (en) | Pyridone modified zinc phthalocyanine and preparation method and application thereof | |
CN109942395A (en) | A kind of curcumin ionic liquid and its application | |
US10208077B1 (en) | Aesculin lipoic acid ester with antioxidant activity and a method of preparing the same | |
US10208078B1 (en) | Aesculin thiodipropionic acid ester with antioxidant activity and a method of preparing the same | |
US10487094B1 (en) | Bergenin thiodipropionic acid ester with antioxidant activity and a method of improving the antioxidant property of ganoderma lucidum spore oil using the same | |
JP6125532B2 (en) | Acridinedione derivatives for the treatment of pigmentation diseases and skin aging | |
US10995053B1 (en) | Hydroxytyrosol ursolic acid ester with antioxidant activity and methods of preparing the same | |
CN108484471B (en) | Compound for dyeing hair and single-agent hair dye containing compound | |
CN102898503B (en) | Antioxidation-activity synthetic peptides and application thereof | |
KR102423643B1 (en) | Method For Astaxanthin Monoester Through Transesterification | |
US10494377B1 (en) | Bergenin lipoic acid ester with antioxidant activity and a method of preparing the same | |
KR101931442B1 (en) | A novel compound having anti-oxidant or anti-inflammatory activity | |
CN114716400B (en) | Cosmetic active substance tocopheryl ester and green synthesis method thereof | |
US10343988B1 (en) | Hydroxytyrosol thiodipropionic acid ester with antioxidant activity and a method of preparing the same | |
CN108440644B (en) | Porphyrin dimer with high water solubility and application thereof | |
CN111328281B (en) | Polyketide and derivatives thereof for preventing and treating neurological disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190621 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200630 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200720 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6741315 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |